Exploring the therapeutic potential of silkworm pupae extract and stromal vascular fraction in diabetic wound healing.
Khosropanah MH., Hassannejad Z., Azimzadeh A., Tanourlouee SB., Ghofrani A., Mohebbi A.
Animal Study on Diabetic Foot, Chronic Wound, Chronic Inflammation, published in Tissue Cell (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Tissue Cell (2025)
- Country
- Scotland
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41353903
- DOI
- 10.1016/j.tice.2025.103231
- Citations
- 1
Abstract (original English)
Chronic wounds from diabetes mellitus (DM), a global health issue, may be healed by silkworm cocoon extract's antibacterial, anti-inflammatory, and antioxidant capabilities. Silkworm pupae extract was characterized based on the concentration and type of amino acids and proteins through Bradford assay, SDS-PAGE, and LC-MS/MS. For diabetic rat wound treatment, the extract was incorporated into silk fibroin/chitosan/hydrogel. Histology, immunohistochemistry, inflammation, neovascularization, and epidermal thickness were measured using ImageJ software over 3, 7, 14, and 21 days with or without stromal vascular fraction (SVF) cells to assess regeneration potential. On day 14, pupae extract and SVF cell hydrogels reduced inflammation. Both components reduced inflammation on day 7, however by day 14 there was insignificant difference from the control group. Neovascularization increased with pupae extract or a combination at days 3 and 7, but not 14 and 21. Epidermal thickness increased on days 7 and 14, whereas pupae extract and SVF cell collagen deposition peaked on days 14 and 21. We observed treatment effects on days 7 and 14, observing collagen deposition on days 14 and 21 (p < 0.01). While SVF group alone had less significant outcomes, the pupae extract with the SVF group responded most therapeutically, followed by the other group.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations